{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-042057","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.396531+00:00","generated_at":"2026-05-15T06:47:08.121905+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Adial grants RSAs to CEO, CFO, COO, and directors; options to director","bullets":["CEO Cary Claiborne receives 37,985 RSAs (28,800 as CEO, 9,185 as director).","CFO Vinay Shah receives 17,325 RSAs; COO Tony Goodman receives 26,510 RSAs.","Directors Schuyler and Gilliland each get 9,185 RSAs; Anderson gets options for 9,185 shares at $1.64.","All awards vest on the earlier of one-year anniversary or change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-042057","json":"https://secwatch.observer/filing/0001213900-26-042057.json","markdown":"https://secwatch.observer/filing/0001213900-26-042057.md","text":"https://secwatch.observer/filing/0001213900-26-042057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026042057/0001213900-26-042057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026042057/ea0285772-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:47:08.121905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}